MDEs miR-let-7a-5p can be transferred to lung cancer cells, resulting in the inhibition of cell growth, migration, and invasion through the downregulation of Bcl2-like 1 (BCL2L1) expression (67). Here, BCL2L1 is linked to lung carcinoma.